Insulin Degludec Versus Glargine U300 for the Management of Hospitalized Patients With Type 2 Diabetes: Randomized Controlled Trial
Latest Information Update: 08 Mar 2022
At a glance
- Drugs Insulin degludec (Primary) ; Insulin aspart; Insulin glargine
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 03 Mar 2022 Status changed from recruiting to completed.
- 23 Oct 2021 Planned number of patients changed from 180 to 220.
- 20 Oct 2021 Status changed from not yet recruiting to recruiting.